UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiotoxicity of trastuzumab emtansine (T-DM1): a single-center experience

Journal of international medical research, 2021-12, Vol.49 (12), p.3000605211053755-3000605211053755

2021

Volltextzugriff (PDF)

Frontline Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Statement by the Africa Middle East Cancer Inter-group [AMCI]

Current women's health reviews, 2024-01, Vol.20 (1)

2024

Volltextzugriff (PDF)

Atypical sweet syndrome in the hands of small cell lung cancer patient associated with granulocyte colony-stimulating factor administration

Journal of oncological science, 2018-12, Vol.4 (3), p.149-150

2018

Volltextzugriff (PDF)

Malignant pleural mesothelioma: a single-center experience in Turkey

Medical science monitor, 2014-05, Vol.20, p.825-832

2014

Volltextzugriff (PDF)

Multifocal soft tissue Langerhans’ cell histiocytosis treated with PET-CT based conformal radiotherapy

Japanese journal of radiology, 2015-09, Vol.33 (9), p.603-606

2015

Volltextzugriff (PDF)

Prognostic and predictive role of FOXP3 positive tumor infiltrating lymphocytes (TILs) in curatively resected non small cell lung cancer other than stage IA

Journal of oncological science, 2017-12, Vol.3 (3), p.102-106

2017

Volltextzugriff (PDF)

Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment?

Medical science monitor, 2014-03, Vol.20, p.428-433

2014

Volltextzugriff (PDF)

Abstract P4-12-30: Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P4-P4-12-30

2020

Volltextzugriff (PDF)

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

The New England journal of medicine, 2023-11, Vol.389 (22), p.2039-2051

2023

Volltextzugriff (PDF)

Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine

Cutaneous and ocular toxicology, 2010-06, Vol.29 (2), p.140-142

2010

Volltextzugriff (PDF)

Scleroderma after 5-fluorouracil and folinic acid therapy in a patient with colon carcinoma

Çukurova Üniversitesi tip fakültesi dergisi, 2014-06, Vol.39 (2)

2014

Volltextzugriff (PDF)

Efficacy and safety results by age in monarchE: Adjuvant abemaciclib combined with endocrine therapy (ET) in patients with HR+, HER2-, node-positive, high-risk early breast cancer (EBC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.501-501

2023

Volltextzugriff (PDF)

Outcomes by complete response to first-line pembrolizumab or platinum-based chemotherapy in advanced urothelial carcinoma (UC) in KEYNOTE-361

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4513-4513

2023

Volltextzugriff (PDF)

Thoracic Radiotherapy Effect on the Outcome in Extensive Stage Small Cell Lung Cancer

Journal of the College of Physicians and Surgeons--Pakistan, 2023-02, Vol.33 (2), p.188-192

2023

Volltextzugriff (PDF)

Clinicohistopathological features and treatment outcomes in testicular lymphomas: A single center experience

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16533-e16533

2018

Volltextzugriff (PDF)

SKYSCRAPER-02: Primary results of a phase III, randomized, double-blind, placebo-controlled study of atezolizumab (atezo) + carboplatin + etoposide (CE) with or without tiragolumab (tira) in patients (pts) with untreated extensive-stage small cell lung cancer (ES-SCLC)

Journal of clinical oncology, 2022-06, Vol.40 (17_suppl), p.LBA8507-LBA8507

2022

Volltextzugriff (PDF)

Clinical efficacy and safety of the BAT1706 (proposed bevacizumab biosimilar) compared with reference bevacizumab in patients with advanced nonsquamous NSCLC: A randomized, double-blind, phase III study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9041-9041

2022

Volltextzugriff (PDF)

Abstract 785: Genomic markers of response to monotherapy abemaciclib in the nextMONARCH 1 study

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.785-785

2020

Volltextzugriff (PDF)

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

Journal of clinical oncology, 2024-06

2024

Volltextzugriff (PDF)

Abstract CT178: Olaparib plus pembrolizumab in patients with previously treated advanced solid tumors with homologous recombination repair mutation (HRRm) and/or homologous recombination deficiency (HRD): Initial results of the phase 2 KEYLYNK-007 study

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT178-CT178

2021

Volltextzugriff (PDF)

Evaluation of flare phenomena in advanced colorectal cancer after bevacizumab cessation in the well-responded cases

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e15019-e15019

2016

Volltextzugriff (PDF)

Correlation of histopahologic response and prognostic markers with survival in locally advanced non-small cell lung cancer patients who have treated with neoadjuvant chemotherapy

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e18521-e18521

2015

Volltextzugriff (PDF)

Trifluridine/tipiracil (FTD/TPI) in patients (pts) aged ≥65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4037-4037

2019

Volltextzugriff (PDF)

Outcomes of Turkish National Breast Cancer Registry

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12517-e12517

2017

Volltextzugriff (PDF)

Characteristics of Turkish colorectal cancer patients and bevacizumab preference

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e15055-e15055

2017

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(30)
Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Male
(18)
Middle Aged
(16)
Aged
(13)
Female
(12)
Adult
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
General & Internal Medicine
(7)
Medicine, General & Internal
(7)
Biological And Medical Sciences
(5)
Chemotherapy
(5)
Lung Cancer
(5)
Medical Sciences
(5)
Risk Factors
(5)
Treatment Outcome
(5)
Aged, 80 And Over
(4)
Cisplatin - Administration & Dosage
(4)
Medicine, Research & Experimental
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cardiotoxicity of trastuzumab emtansine (T-DM1): a single-center experience

Frontline Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Statement by the Africa Middle East Cancer Inter-group [AMCI]

Atypical sweet syndrome in the hands of small cell lung cancer patient associated with granulocyte colony-stimulating factor administration

Malignant pleural mesothelioma: a single-center experience in Turkey

Multifocal soft tissue Langerhans’ cell histiocytosis treated with PET-CT based conformal radiotherapy

Prognostic and predictive role of FOXP3 positive tumor infiltrating lymphocytes (TILs) in curatively resected non small cell lung cancer other than stage IA

Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment?

Abstract P4-12-30: Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine

Scleroderma after 5-fluorouracil and folinic acid therapy in a patient with colon carcinoma

Efficacy and safety results by age in monarchE: Adjuvant abemaciclib combined with endocrine therapy (ET) in patients with HR+, HER2-, node-positive, high-risk early breast cancer (EBC)

Outcomes by complete response to first-line pembrolizumab or platinum-based chemotherapy in advanced urothelial carcinoma (UC) in KEYNOTE-361

Thoracic Radiotherapy Effect on the Outcome in Extensive Stage Small Cell Lung Cancer

Clinicohistopathological features and treatment outcomes in testicular lymphomas: A single center experience

SKYSCRAPER-02: Primary results of a phase III, randomized, double-blind, placebo-controlled study of atezolizumab (atezo) + carboplatin + etoposide (CE) with or without tiragolumab (tira) in patients (pts) with untreated extensive-stage small cell lung cancer (ES-SCLC)

Clinical efficacy and safety of the BAT1706 (proposed bevacizumab biosimilar) compared with reference bevacizumab in patients with advanced nonsquamous NSCLC: A randomized, double-blind, phase III study

Abstract 785: Genomic markers of response to monotherapy abemaciclib in the nextMONARCH 1 study

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

Abstract CT178: Olaparib plus pembrolizumab in patients with previously treated advanced solid tumors with homologous recombination repair mutation (HRRm) and/or homologous recombination deficiency (HRD): Initial results of the phase 2 KEYLYNK-007 study

Evaluation of flare phenomena in advanced colorectal cancer after bevacizumab cessation in the well-responded cases

Correlation of histopahologic response and prognostic markers with survival in locally advanced non-small cell lung cancer patients who have treated with neoadjuvant chemotherapy

Trifluridine/tipiracil (FTD/TPI) in patients (pts) aged ≥65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS

Outcomes of Turkish National Breast Cancer Registry

Characteristics of Turkish colorectal cancer patients and bevacizumab preference

Aktive Filter

Suchergebnisse filtern